Download presentation
Presentation is loading. Please wait.
Published byGrant Lane Modified over 9 years ago
2
Brief (<15 min), generalized, tonic- clonic seizure associated with a febrile illness, but without any CNS infection, severe metabolic disturbance, or other known neurological cause The most common seizure disorder during childhood
3
Age: 6 m/o ~ 5 y/o Incidence: 2% ~ 4% in children <5 y/o Peak age of onset: 18 ~ 22 m/o Sex: male = female Strong family history in siblings and parents: increase risk 2~3 times
4
Viral URI Reseola Acute otitis media
5
80~90% of cases Occur early when core temperature reaches 39 C or greater Generalized, tonic-clonic for seconds to 15-min, followed by a postictal period of drowsiness
6
Age 5 y/o Onset >24 hr after fever onset Duration >15 min Occur more than once in 24 hr Focal motor manifestations Abnormal neurological examination
7
Typical: not required Atypical: required EEG Toxicology screening Assessment of electrolytes CT or MRI
8
Routine treatment: Search for the cause of fever Control fever (avoid excessive clothing, encourage fluids, tepid sponge bath, and antipyretics) Prophylactic anticonvulsants are not indicated for typical febrile convulsion
9
Excellent prognosis in most children Risk of recurrence: Onset < 1 y/o or with family history: 50% Onset > 1 y/o: 30 % up to the age of 5 yr After second episode: 50 % Age > 5 y/o: near zero
10
Risk of epilepsy development: 1~2% in the general population increase up to 9% when two or more risk factors are present
11
Risk factors for epilepsy development: Positive family history of epilepsy Atypical febrile convulsion Previous abnormal development or neurological disorder
12
Antipyretic agents: ineffective Diazepam: effective and safe Oral or rectal form For patients with frequent febrile convulsion or significant parental anxiety Dose: 0.3 mg/kg q8h PO (1 mg/kg/d) for the duration of the illness (2~3 days) Side effects: lethargy, irritable, ataxia
13
Thank You for Your Attention !
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.